Article info

PDF
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma

Authors

  1. Correspondence to Dr Marco Agostini, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy; m.agostini{at}unipd.it
View Full Text

Citation

D'Angelo E, Zanon C, Sensi F, et al
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma

Publication history

  • Received 20 July 2017
  • Revised 8 August 2017
  • Accepted 9 August 2017
  • Published in print 12 September 2017.
  • Published first 4 September 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.